ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 116 filers reported holding ENZO BIOCHEM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | -28.6% | 1,804 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 1,804 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | +20.0% | 1,804 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 1,804 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -66.7% | 1,804 | -52.6% | 0.00% | – |
| Q3 2018 | $15,000 | +200.0% | 3,804 | +253.5% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 1,076 | +7.6% | 0.00% | – |
| Q1 2018 | $5,000 | -37.5% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -9.1% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | +37.5% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
| CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
| KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
| First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
| Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
| MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
| Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
| EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
| ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |